Although it is objectively recognized that FOXC1 plays a dual role in breast cancer, in actuality, its function in augmenting the invasiveness of breast cancer—particularly in triple-negative breast cancer (TNBC) and basal-like breast cancer (BLBC)—has been more extensively researched. Here, FOXC1 is linked to breast cancer.